What is the treatment of choice for prolactinomas?

Updated: Mar 25, 2018
  • Author: Venkatesh Babu Segu, MD, MBBS, DM; Chief Editor: Romesh Khardori, MD, PhD, FACP  more...
  • Print

Treatment is indicated if mass effects from the tumor and/or significant effects from hyperprolactinemia are present. [8]  Bromocriptine (BEC) is generally considered to be the agent of choice in the treatment of prolactinoma because of its long track record and safety. As a dopamine (DA) agonist, it decreases the synthesis and secretion of PRL. [9] It also decreases the rate of tumor cell division and the growth of individual cells.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!